Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Electrocardiographic Q-wave "remodeling" in reperfused ST-segment elevation myocardial infarction: validation study with CMR.

Florian A, Slavich M, Masci PG, Janssens S, Bogaert J.

JACC Cardiovasc Imaging. 2012 Oct;5(10):1003-13. doi: 10.1016/j.jcmg.2012.02.018.

2.

DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes.

Connelly KA, Zhang Y, Advani A, Advani SL, Thai K, Yuen DA, Gilbert RE.

Cardiovasc Ther. 2013 Oct;31(5):259-67. doi: 10.1111/1755-5922.12005.

PMID:
22963483
3.

MEK1-induced physiological hypertrophy inhibits chronic post-myocardial infarction remodeling in mice.

Yeh CC, Malhotra D, Yang YL, Xu Y, Fan Y, Li H, Mann MJ.

J Cell Biochem. 2013 Jan;114(1):47-55. doi: 10.1002/jcb.24299.

PMID:
22821618
4.

A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral.

Tereshchenko LG, Cheng A, Fetics BJ, Butcher B, Marine JE, Spragg DD, Sinha S, Dalal D, Calkins H, Tomaselli GF, Berger RD.

J Electrocardiol. 2011 Mar-Apr;44(2):208-16. doi: 10.1016/j.jelectrocard.2010.08.012. Epub 2010 Nov 20.

5.

Ventricular arrhythmia is predicted by sum absolute QRST integralbut not by QRS width.

Tereshchenko LG, Cheng A, Fetics BJ, Marine JE, Spragg DD, Sinha S, Calkins H, Tomaselli GF, Berger RD.

J Electrocardiol. 2010 Nov-Dec;43(6):548-52. doi: 10.1016/j.jelectrocard.2010.07.013. Epub 2010 Sep 15.

6.

Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients.

Tereshchenko LG, Han L, Cheng A, Marine JE, Spragg DD, Sinha S, Dalal D, Calkins H, Tomaselli GF, Berger RD.

Heart Rhythm. 2010 Nov;7(11):1606-13. doi: 10.1016/j.hrthm.2010.08.022. Epub 2010 Sep 29.

7.

11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardium.

Fallavollita JA, Banas MD, Suzuki G, deKemp RA, Sajjad M, Canty JM Jr.

J Nucl Cardiol. 2010 Jan-Feb;17(1):85-96. doi: 10.1007/s12350-009-9164-z. Epub 2009 Nov 10.

8.

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy.

Ostman-Smith I, Wisten A, Nylander E, Bratt EL, Granelli Ad, Oulhaj A, Ljungström E.

Eur Heart J. 2010 Feb;31(4):439-49. doi: 10.1093/eurheartj/ehp443. Epub 2009 Nov 5.

9.

Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study.

Bacharova L, Szathmary V, Kovalcik M, Mateasik A.

J Electrocardiol. 2010 May-Jun;43(3):200-8. doi: 10.1016/j.jelectrocard.2009.07.014. Epub 2009 Aug 26.

PMID:
19709670
10.

QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.

Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM.

Eur Heart J. 2009 Dec;30(23):2908-14. doi: 10.1093/eurheartj/ehp321. Epub 2009 Aug 17.

PMID:
19687165
11.

Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.

Okin PM.

J Electrocardiol. 2009 Nov-Dec;42(6):584-8. doi: 10.1016/j.jelectrocard.2009.06.020. Epub 2009 Jul 24.

PMID:
19631946
12.

Gender differences and risk of ventricular tachycardia or ventricular fibrillation.

Haigney MC, Zareba W, Nasir JM, McNitt S, McAdams D, Gentlesk PJ, Goldstein RE, Moss AJ; MADIT II Investigators.

Heart Rhythm. 2009 Feb;6(2):180-6. doi: 10.1016/j.hrthm.2008.10.045. Epub 2008 Nov 6.

PMID:
19187907
13.

The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR.

J Am Coll Cardiol. 2008 Dec 16;52(25):2148-55. doi: 10.1016/j.jacc.2008.09.014.

14.

Implantable cardioverter-defibrillators after myocardial infarction.

Myerburg RJ.

N Engl J Med. 2008 Nov 20;359(21):2245-53. doi: 10.1056/NEJMra0803409. Review. No abstract available.

PMID:
19020326
15.

Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Dhar R, Alsheikh-Ali AA, Estes NA 3rd, Moss AJ, Zareba W, Daubert JP, Greenberg H, Case RB, Kent DM.

Heart Rhythm. 2008 Jun;5(6):807-13. doi: 10.1016/j.hrthm.2008.02.013. Epub 2008 Feb 16.

16.

Prognostic significance of fragmented QRS complex for predicting the risk of recurrent cardiac events in patients with Q-wave myocardial infarction.

Pietrasik G, Goldenberg I, Zdzienicka J, Moss AJ, Zareba W.

Am J Cardiol. 2007 Aug 15;100(4):583-6. Epub 2007 Jun 29.

PMID:
17697810
17.

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.

Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.

Circulation. 2007 Aug 14;116(7):700-5. Epub 2007 Jul 30.

18.

Repolarization variability in the risk stratification of MADIT II patients.

Couderc JP, Zareba W, McNitt S, Maison-Blanche P, Moss AJ.

Europace. 2007 Sep;9(9):717-23. Epub 2007 Jul 17.

PMID:
17639070
19.

Electrical and structural remodeling in left ventricular hypertrophy-a substrate for a decrease in QRS voltage?

Bacharova L.

Ann Noninvasive Electrocardiol. 2007 Jul;12(3):260-73. Review.

PMID:
17617072
20.

Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.

Bunch TJ, Hohnloser SH, Gersh BJ.

Circulation. 2007 May 8;115(18):2451-7. Review. No abstract available.

Supplemental Content

Support Center